Literature DB >> 15386720

Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database.

Janet R Hardy1, Theodore R Holford, Gillian C Hall, Michael B Bracken.   

Abstract

PURPOSE: To develop a method for identifying the beginning and ending records of pregnancies in the automated medical records of the General Practice Research Database (GPRD).
METHODS: Women's records from 1991 to 1999 were searched for codes from 17 pregnancy marker and 7 pregnancy outcome categories. Using the retrieved records, all possible pregnancy marker-outcome combinations were formed per woman. For each combination, the difference in days between record event dates was calculated. Restrictions were applied to select the combination with the earliest pregnancy marker mapped to the first outcome for each pregnancy. Iterations of the algorithm identified multiple pregnancies per woman when present. The algorithm was evaluated by analyzing time between marker and outcome event dates of mapped pregnancies and by analyzing unmapped pregnancy markers and outcomes.
RESULTS: A total of 297,082 pregnancies were identified: 80% by general practitioner (GP) visit codes as the earliest pregnancy marker and 14% by laboratory or procedure codes. Limiting pregnancies to one per woman aged 15-44 years yielded 209,266 pregnancies. Pregnancy mapping success was greater than 80%. Plotting the pregnancies by weeks from earliest pregnancy marker to outcome and by pregnancy marker category showed two peaks in the distribution: 2-3 weeks and 33 weeks.
CONCLUSIONS: Arranging codes and time into algorithms provides a useful tool for pregnancy identification in databases whose size prohibits the audit of printed records. Evaluation of our algorithm confirmed a high degree of mapping success and a sensible time distribution from pregnancy marker to outcome. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15386720     DOI: 10.1002/pds.935

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  14 in total

1.  Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.

Authors:  Jamie J Coleman; Sarah E McDowell; Stephen J W Evans; Paramjit S Gill; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 2.  Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries.

Authors:  Rachel A Charlton; Marianne C Cunnington; Corinne S de Vries; John G Weil
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.

Authors:  Cormac J Sammon; Anita McGrogan; Julia Snowball; Corinne S de Vries
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452

4.  Maternal Pre-pregnancy Body Mass Index and Autism Spectrum Disorder among Offspring: A Population-Based Case-Control Study.

Authors:  Kelly D Getz; Marlene T Anderka; Martha M Werler; Susan S Jick
Journal:  Paediatr Perinat Epidemiol       Date:  2016-05-30       Impact factor: 3.980

5.  Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study.

Authors:  Daniel B Horton; Frank I Scott; Kevin Haynes; Mary E Putt; Carlos D Rose; James D Lewis; Brian L Strom
Journal:  Pediatrics       Date:  2015-07-20       Impact factor: 7.124

6.  Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.

Authors:  Rachel A Charlton; John G Weil; Marianne C Cunnington; Sayantani Ray; Corinne S de Vries
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

7.  No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.

Authors:  Salaheddin M Mahmud; Paul Van Caeseele; Gregory Hammond; Carol Kurbis; Tim Hilderman; Lawrence Elliott
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

8.  Developing and Validating Methods to Assemble Systemic Lupus Erythematosus Births in the Electronic Health Record.

Authors:  April Barnado; Amanda M Eudy; Ashley Blaske; Lee Wheless; Katie Kirchoff; Jim C Oates; Megan E B Clowse
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-16       Impact factor: 5.178

9.  Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD.

Authors:  Cormac J Sammon; Julia Snowball; Anita McGrogan; Corinne S de Vries
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?

Authors:  Salaheddin M Mahmud; Songul Bozat-Emre; Gregory Hammond; Lawrence Elliott; Paul Van Caeseele
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.